ArticleInternational journal of nanomedicine2025

A Hybrid Protein-Oxygen Nanomedicine Overcomes Osimertinib Resistance in NSCLC via HIF-1α/VEGF/EGFR Inhibition.

Guanming Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.